BlueCross BlueShield of Tennessee Medical Policy Manual

Axial Lumbosacral Interbody Fusion

DESCRIPTION

Axial lumbosacral interbody fusion (LIF) may also be referred to as pre-sacral, trans-sacral or paracoccygeal interbody fusion.  It is a minimally invasive technique designed to provide anterior access to the L4-S1 disc spaces for interbody fusion (e.g. AxiaLIF® and AxiaLIF® II Level systems) The procedure has been proposed to relieve back pain by providing anterior stabilization of the spinal segments as an adjunct to spinal fusion.  

The LIF procedure is distinctly different from other open fusion approaches. The lumbar vertebrae are accessed via a small incision in the precoccygeal area perpendicular to the plane that is used for other fusion procedures. Fluoroscopy is utilized for guidance of the instrumentation as well as peri-operative monitoring of the surgical manipulation. Following debulking of the nucleus pulposus, bone graft material is injected to fill the disc space. A threaded rod designed to distract the vertebral bodies and to restore disc and neural foramen height is implanted in the affected vertebrae. Additional graft material is injected to secure the rod. Percutaneous placement of pedicle or facet screws may be used to provide supplemental fixation.

While this procedure may allow preservation of the annulus and paraspinous soft tissue structures, there is an inability to address intracanal pathology or visualize the discectomy procedure directly. Complications of the axial approach may include perforation of the bowel and injury to blood vessels and/or nerves.

POLICY

IMPORTANT REMINDERS

ADDITIONAL INFORMATION

The published literature on axial lumbar interbody fusion consists of retrospective reviews.  Due to the variable natural history of the disorder and the subjective nature of the main outcomes, this evidence is insufficient to evaluate whether axial LIF is as effective or as safe as other surgical approaches to lumbosacral interbody fusion.

SOURCES 

BlueCross BlueShield Association. Medical Policy Reference Manual. (4:2018). Axial lumbosacral interbody fusion (7.01.130). Retrieved August 27, 2018 from BlueWeb. (14 articles and/or guidelines reviewed)

National Institute for Health and Care Excellence. (2018, July). Transaxial interbody lumbosacral fusion for severe chronic low back pain. Retrieved August 27, 2018 from www.nice.org.uk/guideance/ipg620.

Schroeder, G. D., Kepler, C. K., Mba, M. D., & Vaccaro, A. R. (2015). Axial interbody arthrodesis of the L5-S1 segment: a systematic review of the literature. Journal of Neurosurgery: Spine, 23 (3), 314-319. Abstract retrieved October 21, 2015 from PubMed database.

Schroeder, G.D., Kepler, C.K., Millhouse, P.W., Fleischman, A.N., Maltenfort, M.G., Bateman, D.K., & Vaccaro, A.R. (2016). L5/S1 fusion rates in degenerative spine surgery: a systematic review comparing ALIF, TLIF, and axial interbody arthrodesis. Clinical Spine Surgery, 29 (4), 150-155. Abstract retrieved August 27, 2018 from PubMed database.

Tobler, W., Melgar, M., Raley, T., Anand, N., Miller, L., & Nasca, R. (2013).  Clinical and radiographic outcomes with L4-S1 axial lumbar interbody fusion (AxiaLIF) and posterior instrumentation: a multicenter study. Medical Devices: Evidence and Research, 13 (6), 155-161. (Level 4 evidence)

U. S. Food and Drug Administration. (2008, April). Center for Devices and Radiological Health. 501(k) Summary. K050965. Retrieved April 23, 2014 from http://www.accessdata.fda.gov

Zeilstra, D., Miller, L., Block, J. (2013).  Axial lumbar interbody fusion: a 6-year single-center experience. Clinical Interventions in Aging, 13 (8), 1063-1069. (Level 3 evidence)

Zeilstra, D., Staartjes, V., and Schröder, M. (2017). Minimally invasive transaxial lumbosacral interbody fusion: a ten year single-centre experience. International Orthopedics, 41 (1), 113-119. Abstract retrieved September 11, 2017 from PubMed database.

ORIGINAL EFFECTIVE DATE:  5/11/2013

MOST RECENT REVIEW DATE:  11/8/2018

ID_BA

Policies included in the Medical Policy Manual are not intended to certify coverage availability. They are medical determinations about a particular technology, service, drug, etc. While a policy or technology may be medically necessary, it could be excluded in a member's benefit plan. Please check with the appropriate claims department to determine if the service in question is a covered service under a particular benefit plan. Use of the Medical Policy Manual is not intended to replace independent medical judgment for treatment of individuals. The content on this Web site is not intended to be a substitute for professional medical advice in any way. Always seek the advice of your physician or other qualified health care provider if you have questions regarding a medical condition or treatment.

This document has been classified as public information.